Renaissance Technologies - ICU MED INC ownership

ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 248 filers reported holding ICU MED INC in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ICU MED INC
ValueSharesWeighting
Q2 2023$15,324
+239.0%
86,000
+213.9%
0.02%
+266.7%
Q1 2023$4,520
+233.8%
27,400
+218.6%
0.01%
+200.0%
Q4 2022$1,354
-100.0%
8,600
-81.8%
0.00%
-80.0%
Q3 2022$7,108,000
-47.6%
47,200
-42.8%
0.01%
-37.5%
Q2 2022$13,562,000
-5.7%
82,500
+27.7%
0.02%
-5.9%
Q1 2022$14,383,000
-19.2%
64,600
-13.9%
0.02%
-22.7%
Q4 2021$17,801,000
-17.5%
75,000
-18.8%
0.02%
-21.4%
Q3 2021$21,564,000
+89.5%
92,400
+67.1%
0.03%
+100.0%
Q2 2021$11,381,000
+73.1%
55,300
+72.8%
0.01%
+75.0%
Q1 2021$6,574,000
+63.0%
32,000
+70.2%
0.01%
+100.0%
Q4 2020$4,032,000
-49.6%
18,800
-57.1%
0.00%
-50.0%
Q3 2020$8,005,000
+239.3%
43,800
+242.2%
0.01%
+300.0%
Q2 2020$2,359,000
+387.4%
12,800
+433.3%
0.00%
Q1 2020$484,000
-78.9%
2,400
-73.6%
0.00%
-100.0%
Q2 2019$2,292,000
-86.9%
9,100
-88.1%
0.00%
-89.5%
Q4 2018$17,521,000
-70.4%
76,300
-63.5%
0.02%
-68.9%
Q3 2018$59,120,000
-65.2%
209,089
-66.4%
0.06%
-34.4%
Q2 2018$169,783,000
+117.6%
621,600
+101.1%
0.09%
+9.4%
Q1 2018$78,017,000
+8.6%
309,100
-7.1%
0.08%
+7.6%
Q4 2017$71,863,000
-12.7%
332,700
-24.9%
0.08%
-18.6%
Q3 2017$82,332,000
-18.9%
443,000
-24.7%
0.10%
-25.4%
Q2 2017$101,482,000
-4.6%
588,300
-15.6%
0.13%
-12.8%
Q1 2017$106,409,000
-2.4%
696,849
-5.8%
0.15%
-13.4%
Q4 2016$108,995,000
+16.7%
739,700
+0.1%
0.17%
+4.2%
Q3 2016$93,395,000
+4.4%
739,000
-6.8%
0.16%
-2.9%
Q2 2016$89,422,000
+2.0%
793,100
-5.8%
0.17%
+1.8%
Q1 2016$87,652,000
-4.4%
842,000
+3.6%
0.17%
-16.5%
Q4 2015$91,668,000
+9.8%
812,800
+6.6%
0.20%
+0.5%
Q3 2015$83,505,000
+26.7%
762,600
+10.7%
0.20%
+32.7%
Q2 2015$65,884,000
+16.0%
688,734
+13.0%
0.15%
+24.0%
Q1 2015$56,787,000
+27.3%
609,700
+11.9%
0.12%
+12.0%
Q4 2014$44,614,000
+24.6%
544,741
-2.4%
0.11%
+10.2%
Q3 2014$35,806,000
-8.8%
557,900
-13.6%
0.10%
+6.5%
Q2 2014$39,253,000
-10.5%
645,500
-11.8%
0.09%
-12.4%
Q1 2014$43,844,000
+15.0%
732,201
+22.3%
0.10%
+15.4%
Q4 2013$38,130,000
+42.2%
598,500
+51.7%
0.09%
+40.0%
Q3 2013$26,805,000
+46.7%
394,600
+55.6%
0.06%
+35.4%
Q2 2013$18,274,000253,6000.05%
Other shareholders
ICU MED INC shareholders Q4 2016
NameSharesValueWeighting ↓
NUANCE INVESTMENTS, LLC 1,035,101$212,651,0003.97%
EVR Research LP 22,000$4,520,0003.44%
Tamarack Advisers, LP 70,000$14,381,0002.95%
Nitorum Capital, L.P. 252,668$51,908,0002.56%
PFM Health Sciences, LP 290,661$59,713,0001.82%
KIRR MARBACH & CO LLC /IN/ 22,298$4,581,0001.33%
Findlay Park Partners LLP 671,136$137,878,0000.96%
PURA VIDA INVESTMENTS, LLC 148,548$30,518,0000.87%
Redmile Group, LLC 224,154$46,050,0000.65%
Canvas Wealth Advisors, LLC 5,177$1,064,0000.62%
View complete list of ICU MED INC shareholders